On 30 JUNE Texas Instruments Incorporated (NASDAQ:TXN) reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.03. The company had revenue of $2.98 billion for the quarter, compared to the consensus estimate of $2.95 billion. During the same quarter in the previous year, the company posted $0.32 earnings per share. The company’s revenue for the quarter was up 3.4% on a year-over-year basis. Analysts expect that Texas Instruments will post $2.32 EPS for the current fiscal year. Texas Instruments Incorporated (NASDAQ:TXN) net profit margin is 18.30% and weekly performance is 0.98%. On last trading day company shares ended up $48.51. Analysts mean target price for the company is $49.18. Texas Instruments Incorporated (NASDAQ:TXN) distance from 50-day simple moving average (SMA50) is 3.67%.
On 1 JULY Analog Devices, Inc. (NASDAQ:ADI) reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.03. The company had revenue of $694.54 million for the quarter, compared to the consensus estimate of $670.93 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was up 5.4% on a year-over-year basis. Analysts expect that Analog Devices will post $2.36 EPS for the current fiscal year. Analog Devices, Inc. (NASDAQ:ADI) shares fell -0.20% in last trading session and ended the day on $54.41. ADI Gross Margin is 65.30% and its return on assets is 11.30%. Analog Devices, Inc. (NASDAQ:ADI) quarterly performance is 1.36%.
On 26 JUNE Integrated Silicon Solution, Inc. (NASDAQ:ISSI) reported $0.23 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.20 by $0.03. The company had revenue of $80.90 million for the quarter, compared to the consensus estimate of $80.00 million. During the same quarter last year, the company posted $0.21 earnings per share. Integrated Silicon Solution’s revenue was up 7.9% compared to the same quarter last year. On average, analysts predict that Integrated Silicon Solution will post $0.92 earnings per share for the current fiscal year. Integrated Silicon Solution, Inc. (NASDAQ:ISSI) shares moved down -0.20% in last trading session and was closed at $15.28, while trading in range of $15.15 – $15.37. Integrated Silicon Solution, Inc. (NASDAQ:ISSI) year to date (YTD) performance is 26.39%.
On 11 JUNE Maxim Integrated Products Inc. (NASDAQ:MXIM) reported $0.43 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.39 by $0.04. The company had revenue of $606.00 million for the quarter, compared to the consensus estimate of $604.68 million. During the same quarter last year, the company posted $0.45 earnings per share. Maxim Integrated Products’s revenue was up .2% compared to the same quarter last year. Analysts expect that Maxim Integrated Products will post $1.68 EPS for the current fiscal year. Maxim Integrated Products Inc. (NASDAQ:MXIM) ended the last trading day at $34.23. Company weekly volatility is calculated as 1.51% and price to cash ratio as 7.86. Maxim Integrated Products Inc. (NASDAQ:MXIM) showed a positive weekly performance of 0.77%.
On 16 JUNE Biogen Idec Inc (NASDAQ:BIIB) and AbbVie (NYSE: ABBV) announced positive top-line results from the Phase 3 DECIDE clinical trial, designed to evaluate the superiority of once-monthly, subcutaneous daclizumab high-yield process (DAC HYP) when compared to intramuscular interferon beta-1a (IFN β-1a), as a potential treatment for relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS). Results showed that DAC HYP was superior on the study’s primary endpoint, demonstrating a statistically significant 45 percent reduction in annualized relapse rate (ARR) compared to IFN β-1a (p<0.0001). Biogen Idec Inc (NASDAQ:BIIB) net profit margin is 25.00% and weekly performance is 5.16%. On last trading day company shares ended up $331.00. Analysts mean target price for the company is $348.64. Biogen Idec Inc (NASDAQ:BIIB) distance from 50-day simple moving average (SMA50) is 8.96%.